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Objectives: To critically assess centralization policies for highly specialized
surgeries in Europe and North America and propose recommendations.
Background/Methods: Most countries are increasingly forced to maintain
quality medicine at a reasonable cost. An all-inclusive perspective, including
health care providers, payers, society as a whole and patients, has ubiquitously
failed, arguably for different reasons in environments. This special article
follows 3 aims: first, analyze health care policies for centralization in different
countries, second, analyze how centralization strategies affect patient out-
come and other aspects such as medical education and cost, and third, propose
recommendations for centralization, which could apply across continents.
Results: Conflicting interests have led many countries to compromise for a
health care system based on factors beyond best patient-oriented care.
Centralization has been a common strategy, but modalities vary greatly
among countries with no consensus on the minimal requirement for the
number of procedures per center or per surgeon. Most national policies are
either partially or not implemented. Data overwhelmingly indicate that
concentration of complex care or procedures in specialized centers have
positive impacts on quality of care and cost. Countries requiring lower
threshold numbers for centralization, however, may cause inappropriate
expansion of indications, as hospitals struggle to fulfill the criteria. Centrali-
zation requires adjustments in training and credentialing of general and
specialized surgeons, and patient education.
Conclusion/Recommendations: There is an obvious need in most areas for
effective centralization. Unrestrained, purely ‘‘market driven’’ approaches are
deleterious to patients and society. Centralization should not be based solely
on minimal number of procedures, but rather on the multidisciplinary
treatment of complex diseases including well-trained specialists available
around the clock. Audited prospective database with monitoring of quality of
care and cost are mandatory.
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(Ann Surg 2018;268:712–724)
A lmost all countries worldwide are facing major challenges withtheir health care system and related costs. The topic is complex
due to numerous factors and perspectives involved in a network of
health care policies, which are determined by various players,
including politicians, insurance or other payers, hospitals, physi-
cians, and national medical societies. Those policies mirror country-
specific social values and available resources. Surprisingly, patients
are rarely in the center of the debate, although an emerging perspec-
tive, known as value-based medicine, is gaining increasing attention.
Value-based medicine aims at measuring quality of care with end-
points relevant to patients and society as a whole.1,2
Although quality of care at acceptable costs is ubiquitously the
target of accountable health care systems, the definition of quality
remains imprecise, and therefore subjected to versatile interpretation,
or even manipulation, depending on the perspectives. For example, a
country might be satisfied with a goal of spending less than 10% of
gross domestic product (GDP), while another may value offering free
health care to all its inhabitants. An important topic, currently under
scrutiny in most countries, is how to provide complex procedural care
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to their populations with laws or policies ranging from unregulated
free markets to concentration in a single national center.
The European Surgical Association (ESA) is selecting every
year a special topic and lecture of high relevance, preferentially not
only for surgeons but also for the society as a whole. This year, the
focus is on centralization for complex surgical procedures. Centrali-
zation in surgery is a process of concentration of resources, which
includes infrastructure, staff, material, knowledge, and research. This
process should lead to improved quality of care and eventually
increased financial efficiency. How centralization should be imple-
mented remains difficult, as an all-inclusive perspective has ubiqui-
tously failed.
The first relevant description of a relationship between higher
surgical volume and postoperative mortality was reported in 1979 for
12 surgical procedures3 followed by a description of factors associ-
ated with higher mortality rates.4 Today, many elements have been
established in the surgical field, which are associated with incre-
mental improvements in the quality of health care.5 One repetitive
observation is that high-volume institutions are associated with
improved outcome through better knowledge about proper indica-
tions, surgical procedures, and postoperative care.6,7 Another feature
associated with better outcome is the so-called ‘‘rescue phenome-
non’’ meaning the ability to prevent minor postoperative events to
develop to severe complications and eventually death.8
Surprisingly, nearly 40 years after the original publication,3
the process of centralization has not progressed much, although the
topic is increasingly recognized as important. For example, 6 (15%)
of the 40 original presentations this year at ESA are dedicated to
centralization. This special article follows 3 aims: first, to analyze
health care delivery in Europe and North America with a focus on
centralization for complex surgical procedures; second, to analyze
the impact of centralization on outcome based on all available data on
centralization, with a special focus on 2 specific procedures (pan-
creas and esophagus resections), as well as its influence on education
and cost; and third to propose recommendations for the optimal
delivery of complex procedures using a Delphi process among
ESA members.
STUDY DESIGN
Our primary goal was to analyze country-specific strategies of
centralization and their impact on outcomes in surgery. For this
purpose, information on this topic was retrieved from the World
Wide Web, available literature, and country-specific reviews and
national databases. The literature search was based on the PubMed
database and cross-reference methodology. The resulting informa-
tion was presented to a panel of academic surgeons, mostly ESA
members, to propose recommendations for effective centralization
using a Delphi methodology.
Country-specific Analysis
Twenty European countries as well as the USA and Canada
were searched for (1) centralization policies, (2) organization of
centralized health care delivery, and (3) minimal case thresholds with
a special focus on major abdominal surgeries, including liver,
esophagus, pancreas, and rectal resections. Each country-specific
analysis was conducted mostly with a nominated country represen-
tative ESA member.
Outcome-oriented Analysis of Centralization
The effects of hospital and surgeon volume as well as special-
ized training on surgical outcome were analyzed. Mortality and
morbidity rates, length of hospital stay, and rates on failure to rescue
from complications were selected to measure the effect of centrali-
zation. These measures were extracted from actual papers and meta-
analysis studies and the effect size are given as odds ratio (OR) or
hazard ratio (HR) with 95% confidence interval (95% CI). In
addition, a comprehensive outcome analysis with examples in dif-
ferent countries was carried out for two complex gastrointestinal
procedures: esophageal and pancreatic resection.
Perspective-oriented Search on Centralization
A PubMed search was conducted to better understand the
patients’ and surgeons’ perspective on centralization issues. Further-
more, a survey among active ESA members was conducted in order
to find out their attitude to important factors of centralization.
Delphi Method
A second survey was embedded in the Delphi methodology9,10
to propose recommendations for future development strategies in
centralization. The Delphi method is a systematic interactive way of
gaining opinions from a panel of independent experts over 2 or more
rounds of consultations. It is a consensus method, which does not
require face-to-face meetings and can be based on online question-
naires. On the basis of all the information available for the prepara-
tion of this manuscript, a 3-step Delphi process was performed
among all coauthors, which includes 1 representative from each
country involved in the analysis.
CENTRALIZATION POLICIES IN EUROPE AND
NORTH AMERICA
In a first step, we analyzed the centralization policies in
gastrointestinal (GI) surgery in 20 European countries, Canada,
and the USA. Thirteen (65%) from the 20 European countries have
related the definition of minimal volume in terms of activity per
center for selective procedures, and only 5% (1/20) have proposed
minimal case load per surgeon (Table 1). Four countries, the Czech
Republic, Greece, Poland, and Romania, have currently no policy
regarding centralization in GI surgery.
There is a lack of consistence in the way health care policy
makers, typically national and regional governments, define proce-
dures or diseases to be centralized. Austria, Denmark, and
Switzerland, for example, based their choices for centralization on
rarity of disease, complexity with high postoperative morbidity,
structural requirements, and consequently costs, and, when available
on evidence for a volume-outcome relationship. In other countries,
complexity, management with multiple disciplines, and technical
challenges of the procedures followed by the financial burden are the
most common selection criteria, recognizing a need for centralization
for procedures on the esophagus, pancreas, liver, and rectum. Cen-
tralization policies may either relate to procedures on an organ, or be
restricted to specific cancers, for example, pancreatic cancer, or
conditions, such as morbid obesity.
There is an obvious gap between regulations for centralization
and implementation. Although centralization is well implemented in
the field of transplantation, pediatric, and neurosurgery, the reality is
very different for other GI procedures. We document, for example,
that volume thresholds in Austria and Germany are not respected in
spite of legally defined requirements. Perhaps the most striking
deviation is that regulations apply to publicly ‘‘subsidized’’ hospitals
but are not enforced in the private sector. Good examples are the UK
and Switzerland. Main obstacles to centralization are summarized in
Table 2.
A brief comment on each country by alphabetical order
followed by Canada and the USA is provided online (http://links.
lww.com/SLA/B467).11–19,21–23,25–42,44–49 This additional informa-
tion can be downloaded as supplementary material online, http://
links.lww.com/SLA/B467.
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THE IMPACT OF CENTRALIZATION OF SURGERY
ON OUTCOME
The main goals of centralization are the improvement of
quality of care, optimization of use of resources, and eventually
cost saving. The real impact of centralization on outcome, however,
remains vague and is currently under hot debate in many countries. It
is unclear whether positive effects of centralization are mainly
based on center or surgeon volumes, or also on other factors such
as the availability of formally trained specialists. We, therefore,
investigated the impact of center versus surgeon volumes on out-
come. Furthermore, we analyzed the effects of centralization in
pancreas and esophagus surgery in more detail.
Effect of Hospital Volume
Available data correlating center volumewith outcome param-
eters are mainly based on statistics derived from both retrospective
and prospective studies. Of note, positive effects of hospital volume
were less pronounced in prospective (40%) than in retrospective
(79%) studies. For the current analysis, we used mostly 3 systematic
reviews and meta-analysis.51–53
The first observation was that no study identified inferior
outcome for high-volume centers, when compared with low-volume
centers, while 74% reported positive effects. These effects were
mirrored in many outcome measures, including mortality rates (posi-
tive effect in 76%of the studies),morbidity (62%), and shorter hospital
stay (79%). The magnitude of positive effects also varied among the
different types of procedures ranging between 62% and 85%, which
were most evident for esophageal and pancreatic surgery. From these
consistent observations, the logical question is: what is the volume cut-
off associated with improved outcome? There is a wide range of
proposed cut-offs for high-volume centers ranging from21 to 50 cases/
year for pancreatic resection, 6 to 30 for esophageal cancer, and 11 to
70 for colorectal resections. These wide ranges indicate that other key
factors play an important role for the positive impact of centralization.
Therefore, centralization policies focusing exclusively on volume
might not translate to an optimal benefit. There is some evidence that
when hospital volume reaches a certain threshold, the volume outcome
effect reaches a plateau, which then can even be associated with higher
mortality rates (Fig. 1).54–56
Effect of Surgeon Volume
The association of surgeon volume and outcome is less often
reported in the literature, when compared with hospital volume. The
inaugural work by Birkmeyer et al57 suggested that surgeon volume
TABLE 1. Requirement for Minimal Numbers (Resections/Year) Per Center
Country Esophagus Pancreas Liver Rectum Surgeon Volume Legally Enforced
Austria 10 10 10 (20 2018) 10 (15 2018) ND Yes
Belgium ND ND ND ND ND
Czech Republic ND ND ND ND ND
Denmark 80–100 >100 >200 >120 ND
England (UK) 60 80 150 ND Defined
Finland ND ND ND ND ND
Francey 30 30 30 30 ND Yes
Germany 10 10 ND ND ND Yes
Greece 15 20 30 ND ND
Hungary 10 20 30 20 ND
Ireland ND ND ND ND ND
Italy 20 50–100 20 50 ND
Norway 10 10 20 20 ND
Poland ND ND ND ND ND
Portugal 20 20 20 20 ND
Romania ND ND ND ND ND
Spain 6 11 11 15 ND Yes
Sweden ND ND ND ND ND
Switzerland 10 10 10 10 ND Yes
The Netherlands 20 20 20 20 ND Yes
Canada 7 20 50 ND ND
USA 20 20 ND 15 Defined
Not based on minimal numbers but defined catchment areas/health care regions; Denmark, England, and Norway have additionally secured minimal numbers.
yIn France, minimal number of 30 procedures in total for cancer irrespective of the location.
According to the Leapfrog Group.
ND indicates not defined.
Additional information can be downloaded as supplementary material online, http://links.lww.com/SLA/B467.
TABLE 2. Main Obstacles to Centralization
(1) At the level of the health care provider (eg, hospital)
Insufficient infrastructure
Lack of specialized personnel
Long waiting time
Difficult access to a center
Restriction of working hours
(2) At the level of the patient
Resistance to longer travel distance
Resistance to cultural changes (eg, language)
Lack of awareness of better outcome
(3) At the level of the payer (insurance, government)
Concerns from increased cost or charges
(4) At the political level (government, professional societies)
Political decision is not enforced and therefore not applied
Regional interests overcome centralization policies
Discrepancies between public law and civil law (ie, private hospitals are
not under the public law, noncompetition clause not possible in
nonprivate hospitals)
Conflict of interest between societies (eg, specialized vs general
surgeons)
Overwhelming bureaucracy (audit, certification, registries, CME, etc)
Lack of specialization boards
Lack of board recognition among countries
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accounts for a large proportion of the significant effects of hospital
volume; for example, in pancreatic surgery, 55% of the improvement
was attributed to surgeon volume, and 46% in esophagectomy. After
adjusting for the clustering effects in other studies, the short-term
mortality risk is surprisingly not significantly associated with sur-
geon volume, in contrast to the long-term results.58 Obviously, both
surgeon and center volumes influence patient outcomes, but the
strength of the relationship varies according to the complexity of the
surgery and the extent of specific hospital-based services. Esoph-
ageal and pancreatic head resections are complex procedures,
whereas, for example, distal pancreatectomies are less complex to
perform, and liver surgery varies from small wedge resections to
extended hemi-hepatectomies. Therefore, the type of operation
should be taken into account when calculating morbidity and mor-
tality rates, though often complexity of the procedure is not stated
and consequently not included in the risk adjustment. There are
important hospital factors, which may add to the impact of center
volume. For example, resources allocated to intensive care units
(ICUs) differ between countries, with variation in the ratios of total
hospital beds to ICU beds and of nurses to patients ranging from 1:1
to 1:3. Clearly, the availability of ICU and well-trained staff impact
on outcome, and particularly in the ‘‘failure-to-rescue’’ concept.
Furthermore, the qualifications of care providers and surgeons are
not documented.59
When focusing on surgeon volume only, positive effects on
outcome were observed in 74% of studies, including lower mortality
rates (in 71% of studies), fewer complications (81%), and shorter
hospital stay (78%). In addition, no study identified negative effects
of high surgeon volume on outcome.51 However, an evidence-based
surgeon volume threshold cannot be identified. The cut-offs for high
surgeon volume vary in the literature between 4 and 41 cases/year for
pancreatic surgery, 6 and 12 for esophageal resections, and 13 and 33
for colorectal cancer resections. Of note, an increased hospital
volume compensates to certain degree for low-volume surgeons,
but possibly never matching those of high-volume surgeons.60
Effect of Specialization
Over the past 2 to 3 decades, formal specialization in specific
fields of surgery including dedicated periods of training at expert
centers have been developed in many countries with the availability
in Europe and North America of board examinations and certifica-
tion. The benefit of such training on patient outcome is now
established through many studies. In a systematic review,51 such
benefit was evident in the majority of studies (91%), as demonstrated
by lower mortality, shorter hospital stay, fewer complication rates,
and interestingly enhanced academic output, for example, in terms
of publications.
Taken together, it is now established that hospital-surgeon
volumes and specialization are the 3 predominant elements influ-
encing outcome, but the underlying mechanisms are not fully
explored. Two factors regarding volume effect have been proposed:
first the so-called ‘‘selective referral effect’’ to experienced physi-
cians and hospitals because of better outcomes. In this scenario,
better outcome is mostly unrelated to the number of cases. Second,
relies on ‘‘practice-makes perfect,’’ where providers achieve better
outcomes because of increased experience due to more volume. Both
explanations have proven to be valid.61 Thus, volume and speciali-
zation alone may not result in better performance, but act as a proxy
measure for various processes and provider characteristics that
eventually positively influence outcomes.6 Another mechanism for
improved outcome at larger centers is the concept of ‘‘failure-to-
rescue.’’ Although low and high-volume hospitals may have compa-
rable complication rates, high-volume hospitals have a 2.5x lower
mortality rate. One rational explanation is that low-volume hospitals
manage complications poorly. Furthermore, it has been shown, that
low versus high mortality ‘‘failure-to-rescue’’ hospitals tended to
have a closed ICU staffing model (56% vs 20%), as well as a higher
proportion of board-certified intensivists (85% vs 20%), hospitalists
(85% vs 20%), and residents (62% vs 40%). Low mortality ‘‘failure-
to-rescue’’ hospitals provide a better overnight coverage with timely
dedicated response teams.62
After discharge of the patient, hospital readmissions logically
occur more frequently after complex surgeries. Interestingly, read-
mission to the index hospital (hospital where the surgery was done) is
associated with a 26% lower risk of 90-day mortality than readmis-
sion to a nonindex (ie, nonspecialized) hospital. This effect was
significant (P< 0.0001) for all procedures and accounts at largest for
patients, who are readmitted after pancreatectomy (OR 0.56, 95% CI
0.45–0.69).63
The Case of Esophageal Surgery
In-hospital mortality for esophageal cancer resection ranges in
national outcome studies between 7% and 12%.56,64 Overall esoph-
ageal tumor prognosis remains poor with a 5-year survival in the
range of 20% to 30%.56 Surgery on the esophagus represents the most
robust evidence for a reduction in postoperative mortality and
morbidity by concentration of cases in high-volume centers, with
very large centers associated with 1% to 4% mortality rates.65–67 A
meta-analysis covering 16 studies enabled to demonstrate significant
favorable postoperative mortality rates for high-volume providers
(OR, 2.30; 95% CI, 1.89–2.80). Four studies additionally showed
long-term survival benefit for high-volume centers (HR 1.17; 95%
CI, 1.05–1.30).68
A meta-analysis reported in 2004 suggested that a benefit in
postoperative mortality occurs when using a volume threshold of at
least 20 esophagectomies/year.65 In another study, increasing hospi-
tal volume from 20/year to 40 and then 60/year led to incremental
significant decrease in 6-month mortality [HR 0.73 (95% CI (0.65–
0.83) vs 0.67 (0.58–0.77)]. Beyond the threshold of 60 resections per
year, however, no further effect size might occur.54 In the same study,
higher hospital volumewas associated with lower 2-year mortality up
to 50 esophagectomies/year with HR of 0.6 (95% CI 0.79–0.93).
Although it remains unclear where the volume bar for safer esoph-
ageal resection should be set, based on the available data, the bar for
high-volume centers for esophageal resections seems to range
between 20 and 60 resections/year. It appears, however, that there
may be a reversal of these positive volume-outcome associations
when hospital volume exceeds 100 cases/year due to some evidence
for rising mortality rates after this threshold (Fig. 1).56 Studies have
suggested that for esophagectomy, the relation between hospital
volume and outcome is stronger than that of surgeon volume.57,65
Two countries were selected, Germany and Switzerland, to
illustrate the volume outcome effects in esophageal surgery. Further,
a comparative national study for esophageal resections between
England (centralized) and the USA (decentralized) was included.
Among 18,000 patients (data from 2009 to 2014) undergoing esoph-
ageal resection for carcinoma in Germany, adjusted mortality rate
was 5.8% (95% CI 5.1–6.6) on the very high-volume quintile versus
10.5% (95% CI 9.5–11.6) in the very low quintile. Hospital volume
had an independent effect on mortality, and the minimum volume to
fall below the average mortality of 8.5% was calculated as 22 cases
per year.69 A total of 1487 esophageal cancer resections were
performed in Switzerland from 1999 to 2012. The decrease of
postoperative mortality from low-volume (10cases/year) to higher
volume centers ( 11cases/year) was 6.3% versus 3.3%. These
results were confirmed in risk-adjusted analyses with a decreased
odds of postoperative death by 49% (OR 0.51, 95% CI 0.22–1.18;
P ¼ 0.085).43
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The comparison of the in-hospital mortality and length of stay
after esophagectomy between England and the United States
deserves a comment.70 Surgery on the esophagus have been central-
ized in England since 2001, while no formal plan for centralization
exists in the USA. As a result, between 2005 and 2010, 7433
esophagectomies were performed in 66 English hospitals and
5858 resections in 775 US hospitals (Nationwide Inpatient Sample;
NIS); the median number of resections per center/year was 17.5 in
England versus 2 in the USA. In-hospital mortality was higher in US
hospitals (5% vs 4%, P ¼ 0.001). When a subset analysis was done
restricted to high-volume centers, mortality was significantly better
in US hospitals (2.1% vs 3.5%, P¼ 0.02) with shorter LOS in the US
high-volume centers, but not in England.
The Case of Pancreatic Surgery
Pancreatic surgery is one of the most sensitive procedures to
the effect of centralization.71,72 Mortality rates in specialized centers
range between 0% and 5%,20,24,73 but are twice as high in population-
based studies reflecting the real risk of pancreatic procedures at
nonspecialized centers.20,74 The underestimation of the real risk has
been repeatedly observed.20,75,76 A systematic review of studies
adjusted for age and comorbidities showed a significant association
between hospital volume and postoperative mortality (OR 0.32, 95%
CI 0.16–0.64), as well as long-term survival (HR 0.79, 95%CI 0.70–
0.89).77 Positive effects of high-volume centers have also been shown
for postoperative complications, readmission rates, and failure to
rescue.78,79 Similar to esophageal surgery, the volume cut-offs for
high-volume centers remains under debate. A national French study
used sophisticated methodology (spline analysis) to look at minimal
volume for better outcome and identified 2 cut-offs (25 and 65 cases
per year).20 A cut-off at 65 pancreatectomies per year best influenced
the 90-day mortality. Taking centers performing >65 resections per
year as baseline, the adjusted OR of 90-day mortality was 1.86 (95%
CI 1.53–2.28) in centers performing 25 resections per year and
1.23 (95% CI 1.03–1.48) in those performing 26 to 65 resections per
year. Consequently, the second cut-off point is recommended at
25 resections/year giving policy makers and surgeons realizable
goals without abrupt change.
To illustrate volume-outcome effects in pancreatic surgery on
national levels, Germany, Switzerland, and The Netherlands were
selected. In Germany, between 2009 and 2014 pancreatic cancer
resections were performed in 35,000 patients with an adjusted in-
hospital mortality of 6.4% (95% CI 5.8–7.0) in the very high-volume
quintile versus 11.7% (95% CI 10.9–12.5) in the low quintile. The
continuous increment of hospital volume was associated with lower
mortality. The minimum volume, in which the risk of death falls
below the average mortality of 8.8%, was calculated at 29 cases/
year.69 In Switzerland, a total of 2668 pancreatic cancer resections
were performed between 1999 and 2012. Low-volume centers
(20 cases/year) demonstrated a higher postoperative mortality rate
of 5.4% than 2% for higher volume centers (21 cases/year). These
results were also confirmed in a risk-adjusted analysis with a 65%
lower odds of postoperative death (OR 0.32, 95% CI 0.11–0.89; P¼
0.011).43
In the Netherlands, a 10-year lasting plea for centralization
among the surgical community for pancreatic resections, set in 2005,
failed to reduce mortality, likewise due to a failure in changing the
referral pattern.80 One year later, the network of surgical oncologists
in the Western part of the Netherlands agreed to centralize all
pancreatic resection in 2 hospitals, which resulted in an increase
of the 2-year survival rates from 39% to 55%.81 Another important
data from the Dutch Cancer Registry indicated increased resectabil-
ity rates by centralization policies from 10.7% to 15.3%.82 At the
same time, high-volume hospitals reported more R0 resections in the
pancreatic head and distal bile duct tumors than low-volume hospi-
tals (60% vs 54%, P ¼ 0.035), even though they obviously operated
on more advanced tumors (T3/T4) (72% vs 58%, P < 0.001).55 In
another recent Dutch study, the mortality rate for pancreatic resec-
tions decreased nationwide from 9.8% to 5.1% due to centraliza-
tion.83 Nonetheless, the surgical community has come to embrace the
principles and advantages of centralization, although many believe
the threshold of 20 procedures should be increased.
THE IMPACT OF CENTRALIZATION ON SURGICAL
TRAINING
It is difficult to move toward centralization without facing new
challenges for proper training of both general and specialized
surgeons, as well as for other fields in medicine. For example, the
numbers of hospitals in Germany performing esophageal and pan-
creatic surgery decreased, by 44% and 28% within a short period,
respectively.84 Similarly, the Netherlands showed a similar trend with
a significant reduction of hospitals from 160 in 1985 to 79 in 2016.
These developments imply that highly specialized procedures
restricted to some centers should be included in the Board of General
or Visceral Surgery. Such procedures should be performed exclu-
sively by surgeons with extra, and possibly, accredited training in a
specific area of surgery. The ‘‘Union Europe´ene des Me´decins
Spe´cialites’’ (UEMS; www.uems.eu) recognized this issue, propos-
ing a ‘‘grapefruit’’ training model starting with a basic training in
surgery as a foundation to which individual surgeons can add 1 or
more specialties.
However, proper training appears only possible through for-
mal fellowship periods at qualified centers. According to the Ameri-
can College of Surgeons (https://www.facs.org/education/resources/
medical-students/postres), fellowship training allows the trainee
during a designated period (usually 1 to 2 years) to attain additional
training in a surgical specialty, which is beyond the covered intensity
during residency training. The UEMS offers board examinations for
various specialties such as colorectal, HPB, or transplantation sur-
gery. The focus of these examinations is on knowledge in indications
and management of complications in the respective fields of surgery.
Usually 2 years of specialty training are required before being
allowed access to the examination. However, accreditation of train-
ing programs with formalized and quality-controlled fellowship
training is still in early development, and do not secure competence
in performing highly complex procedures. It is essential that fellows
during training are given access to sufficient numbers of cases and
variation of operations, including management of complications, and
exposure to scientific work in the field. After this specialized
training, fellows must be integrated in a specialized team to get
further mentorship and support.
The need for designated and specialized post-residency train-
ing is evident in the USAwith more than 70% of residents entering a
formal training program in a surgical specialty after residency.85
Importantly, training of young surgeons for complex surgeries
through formal fellowship or even residency programs has no nega-
tive impact on patient outcome including mortality and morbidity.56
In fact, a formal training offers a number of positive effects for the
care of patients at many levels.
General surgeons, however, still perform the vast majority of
cancer surgeries, which obviously are not restricted to large insti-
tutions due to logistic and many other reasons. Therefore, an ade-
quate balance of generalized and specialized surgeons must be well
planned in all health care systems to maintain accessibility to high-
quality health care in all geographic areas in a country. Networking
between highly specialized institutions and other hospitals is a key
factor to optimize accessibility of care to patients.
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The tremendous and incessant advances in novel technology
(eg, robotics) requires continuous adjustments in knowledge to
secure optimal care, best available at centralized institution. Here,
the importance of postgraduate education and the increasing need for
training and accreditation for new technical skills cannot be over-
emphasized. To achieve decent knowledge in new technology,
cooperation among specialized centers, scientific organizations,
and industry is paramount.
Finally, working hour restrictions, as regulated in many
countries, make an adequate surgical and subspecialty training
increasingly difficult, not to say impossible.85 These factors further
support the concept of specialized training in an era of centralization,
where complex procedures such as pancreatic or esophageal surgery
are assigned to specialized training tracts.
The Impact of Centralization of Surgery on Cost
One of the aims of centralization, as a consequence of
improvement in quality of care, is to be cost neutral, or better
cost-saving. High-volume compared with low-volume centers have
reduced mortality, morbidity, and ‘‘failure-to-rescue’’ rates,86–88
which logically impact positively on cost.89 It has been shown that
severe complications ( grade IIIb complications) are the single
most important factor affecting total cost of a procedure.90 For
example, in pancreatic surgery, a 5-fold increase in costs was
documented in patients developing severe postoperative complica-
tions versus those with an uneventful course.89 The prevention of
severe complications, therefore, represents an important economic
target for cost-saving.91 To further illustrate the relation between
quality and cost, transthoracic esophagectomy in Germanymay serve
as a good example: The mean costs per uncomplicated case was
reported at 24,338s, which appeared well covered by the DRG
system, but not in the presence of postoperative complications. With
the development of a grade I complication, DRG system leads to a
deficit of 2878s, which increase to 58,543s in presence of a grade
IVb complication. The main cost drivers in case of a complication
can be identified as medical services (22.3%; physician work) and
nonmedical infrastructure (18.7%) and 56% of costs arise on the ICU
and OR (28% each).92
Another study analyzing costs for PD in the USA shows that
there is a significant cost reduction of 15% (with shorter LOS, fewer
ICU admissions), when high-volume surgeons perform the surgery.93
This finding is also confirmed in a systematic review.94
High quality in surgery also confers an important advantage on
long-term, usually oncologic, results such as disease-free survival
and quality of life. Therefore, high quality in surgery should have a
dramatic effect on indirect cost, although data here are missing.
Evidence from a systematic review of the economic impact of
centralization provide strong evidence that increasing surgeon vol-
umes are associated with cost reductions. For example, 1 study
demonstrated that centralization was cost-effective with an incre-
mental cost utility ratio of $5029 (s3616) per quality-adjusted life
year gained (QUALY). 94
Although health care delivery may not compare well with the
manufacturing process in industry, we can learn from industrial
experience with centralized versus decentralized manufacturing.
Centralized manufacturing is associated with lower costs, higher
material turnaround rates with a more efficient production schedule,
more consistent production, and better use of limited resources,
including infrastructure and personnel. The advantages linked to
decentralized strategies are higher flexibility, greater customization,
proximity to customers. Lower tier managers in decentralized
manufacturing companies often have more responsibilities and are
consequently more motivated and creative. Translating this to medi-
cine, it becomes apparent that centralization is unavoidable, but
particular attention must be given to preserve personalized relation-
ship, not only with patients but also among the personal. Thus, it is
tempting to conclude that special resources should be allocated to
these potential shortcomings of larger institution.
Patient Perspective on Centralization
Building on the previous risk of centralization, one well-
recognized disadvantage is an increase in travel demands, thus a
perceived limited access to high-quality care with greater distance
from family and friends. The involvement of patients in the centrali-
zation process is therefore a key component for success. A Swedish
study analyzed the patient’s perspectives on centralization and
identified quality of care (outcome) as the most important factor
to convince patients.95 Additional factors such as a well-functioning
care pathway, individualized care-plans, continuity of treatment with
local providers, accessibility for contact and information, involve-
ment in the care process, and limited waiting time are very important
for patients’ satisfaction. In another study from the UK, patient’s
preference to be treated in a high-volume center was based on a lower
risk of complications and death, and a better access to multidisci-
plinary teams.96 In the same study, patients were willing to travel on
average 75minutes longer in order to reduce their risk of compli-
cations by 1%, and over 5 hours longer to reduce risk of death by 1%.
According to US studies, for many patients, the influence of outcome
data on patients’ hospital selection might be overestimated.97,98 In
case of centralization travel patterns,99 socioeconomic status (eg,
household income) of patients and race/ethnicity100 must be
addressed to reduce and avoid health disparities in multicultural
countries, such as repeatedly noted in the USA.50,101
Surgeons’ Perspective on Centralization
Surgeons in the Netherlands gained experience over the past 2
decades for volume-based policies, with a good acceptance that more
volume leads to better quality.102 They, however, critically empha-
size that hospital volume is more a surrogate marker for the quality of
the infrastructure and processes, rather than the performance of
individual surgeons. Many surgeons complained about the arbitrary
nature of the centralization process due to the under-representation of
surgeons in the national committees that define the volume bar.
Criticisms were also raised that volume bar levels were set without
sufficient evidence. Furthermore, several committee members had
obvious conflict of interest, as they were employees of high-volume
centers. Another complaint related to the ‘‘gate to surgery’’, that is,
indications, which became a bit wider to reach the requested volume
threshold. Most of interviewed surgeons also criticize the attitude of
health insurers for misusing volume discussions and putting some
pressure on health care providers. The ‘‘Take the Volume Pledge’’
campaign in the USA in 2015 tried to promote restriction of 10
surgical procedures to hospitals with minimal annual volume thresh-
olds. In the light of the modest ambition of this campaign, the
response of the surgical community against such a strategy was
disproportionally strong.
Patients’ and surgeons’ perspectives on centralization are in
most of the investigated studies reflecting similar interests and
concerns. Perspectives relate on surgery and do not necessarily apply
to other treatment options (such as chemotherapy), which may be
provided also in a local network hospital.
DISCUSSION
There is currently overwhelmingly evidence in favor of
centralization for complex surgical procedures. Considering the least
biased perspective, that is, the patient perspective, centralization
makes full sense because it offers the best chance for high quality of
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health care for both short and long-term outcomes. The available
literature on centralization as well as the views from local and
national patient associations and most health care payers are consis-
tent with the Delphi process from ESA members, unambiguously
favoring centralized institutions for complex health care delivery,
which represents only about 2% to 3% of all surgical procedure. In
truth, it would be difficult to find anyone, unless living on the moon
for the past 30 years, who could challenge that competence relies on
experience and adequate resources, that is, centralization.
Therefore, the question arises why centralization so poorly
applies to medicine, and in particular, why most countries failed to
implement clear policies for centralization. Health care providers,
and many doctors and nurses, who work close to patients with
complex diseases remain frustrated. Although many countries have
policies or even laws to secure concentration of rare and complex
cases at local or national levels, efficient implementation is notori-
ously not realized, possibly because too many interests are involved.
Hospitals or even states are even using legal ways to reverse or slow
down decisions at the national level for centralization to preserve
prestige, often based on history and personal or institutional interest.
The patient is sadly not in the equation. The authors of this article,
mostly from the European academic world, are standing up here to
make a plea that we should follow the ‘‘Hippocrates oath’’ respecting
1 predominant perspective, that is, the patient. In theory, this should
be easy to understand because each of us, with probably no excep-
tion, will become a patient one day!
So, assuming that centralization is the right concept, how it
should look? The aim is to secure competence in optimally treating a
patient with a complex disorder in a holistic way, rather than just
considering the ability to be able to perform complex procedures.
With this objective, it becomes obvious that focusing just on the
minimal number of procedures per hospital or per surgeon to qualify
for delivering complex surgeries becomes trivial. The criteria to
qualify as an accredited center of excellence should focus on the
disease, rather the number of specific procedures; this is to secure the
optimal delivery of care and importantly the adequate choices for
competitive therapies. The role of a properly structured multidisci-
plinary team is paramount for such decision-making and appropriate
expertise must optimally be available at centralized centers all
around the clock and the year. For example, failure to have an
experienced interventional radiologist on a week-end to treat a
patient with acute bleeding following a pancreato-duodenectomy
may result in a death. Another example is the unavailability of an
interventional gastroenterologist on a holiday day, which may result
in the placement of a cumbersome percutaneous drainage instead of
an ERCP stent in a patient presenting with acute cholangitis.
Having the appropriate setting and staff from the medical
perspective still does not secure quality of care. There is a need for
quality control, which remains one of the major challenges for data
collection and it can be difficult to know which metric to use.
Currently, unconvincing data in many countries offer solid arguments
to those who still lobby against centralization. For example, an
academic public hospital reporting poorer outcome than a pure
‘‘for profit’’ institution targeting a private clientele would claim that
they deal with higher risk populations. Then, an endless ‘‘risk
adjustment’’ debate may ensue, with misleading data typically used
by ‘‘for profit’’ institutions, which put more emphasis on marketing,
to convince the decision makers about their superior results. Proba-
bly, the one with the most convincing marketing tools may win. Do
we want this world in highly specialized medicine? Certainly not
from a patient’s-oriented perspective! For this purpose and credible
comparative measures, a newly benchmark concept was devel-
oped103,104 targeting relevant outcome parameters gathered in
well-defined low risk groups to prevent misleading comparisons
among heterogeneous populations. For example, a large academic
center reports a 35% severe complication rates (eg,> grade III90) on
their complex liver resections, while a ‘‘competitive’’ smaller insti-
tution claims 12%. Unable to understand the difference, most
patients may select the center with the appealing data, which in
reality limits their activity to a low risk cases, and thereby further
contribute to the attractive statistic. In this scenario, the patients are
not aware that many higher risk cases have been turned down to
secure optimal outcomes. Therefore, an easy way to objectively
assess those 2 institutions is to compare the benchmark (low risk)
cases to get meaningful and easy to interpret information. The
proportion of the benchmark cases also readily provides information
of the risk-taking from specific institutions. Not surprisingly, recent
studies have nicely highlighted that centers coping with difficult
cases also do better with the benchmark cases.103 This novel
approach may highly benefit patient-oriented parameters, or newly
called value-based medicine.105 As accreditation would look at the
disease as a whole, quality control should also encompass the whole
process from prevention, diagnosis to treatment, complications, and
survival (and not simply an operation and its survival). It is obvious
that centralization that would only create better results of pancreatic
surgery at the expense of conservative surgical indications or long
waiting times resulting in more drop-outs or inoperable cases, etc,
would be detrimental to the patient.
Aware of the current analysis, members from ESA including at
least 1 from each European country and USA and Canada went
through a Delphi process to propose 12 recommendations (Table 3).
The focus was to propose simple statements applicable to various
TABLE 3. Twelve Recommendations for Centralization
(1) Definition should be based on disease (eg, pancreatic cancer) or on organ systems (eg, complex HPB diseases) rather than a procedure (eg,
esophagectomy or pancreatectomy).
(2) The planning is based on minimal numbers of cases per center and also well distributed among various regions, considering population and cultural
specificities, in a country.
(3) Planning should include at least 2 centers per country to secure choice and competition (except for small countries and very rare diseases).
(4) Appropriate resources must be secured with proper evaluation of available infrastructure and personnel.
(5) Centers must offer fully functioning multidisciplinary teams (MDTs) of specialists capable of tackling all aspects of the diseases all the year around.
(6) Centers must be linked to a network of hospitals to secure adequate referral and follow-up.
(7) Specifications of centralization must be legally enforced for adherence to specifications applied at the local and regional level and for private and
nonprivate hospitals.
(8) The process for centralization must be accompanied by mainstream media activities to secure appropriate awareness of the population.
(9) Centers must have an externally audited database and are actively involved in clinical studies (including RCTs) and should be encouraged to contribute
to laboratory research along with basic scientists.
(10) Quality control must be accompanied by international benchmark comparative studies.
(11) Equal accessibility to centralized health care should be monitored.
(12) Centers must be involved in surgical education, and secure specialized training as well as allowing rotation of ‘‘general surgeons.’’
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health care, political, and economic systems. From the 12 statements,
a few may remain open to debate such the need for centralized
institution to engage in research. Considering that the ESA is a
society for the academic leaders in surgery in Europe, it is no surprise
that a recommendation for clinical research is made, and research is a
society value, which might also be a purpose for centralization.
Such a comprehensive look at centralization is inherently
associated with some limitations. Volume-outcome studies are
mostly observational, retrospective, often follow a time-series
design, and are based on administrative data collected for other
purposes. Many of these studies are from different health care
systems with a great variety in demographical, geographical, and
epidemiological factors and standards of care. NSQIP studies under-
line the major limitations of administrative reviews. Caution
should also be taken by the fact that centers reaching very high
volumes may face poorer outcome, as shown for complex surgeries
and in centralization in other fields such as manufacturing industry
(Fig. 1).
In summary, this task, performed on behalf of the ESA, clearly
establishes the importance of centralization to offer better care in
patients suffering from complex diseases requiring special expertise
and costly technology. The 12 recommendations may serve as a basis
for discussion in various areas to improve health care delivery.
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DISCUSSANTS
Mario Morino (Torino, Italy):
On behalf of all of the members of the ESA, I would like to
congratulate the authors on this very important analysis of centrali-
zation in digestive surgery within Europe.
Centralization implies surgical specialization, and there is no
doubt that this has been a trend in surgery for the past 70 to 80 years.
General surgeons used to perform cardiac surgery, urology, vascular
surgery, etc. Now, we are left with the digestive tract and HPB.
Therefore, my first question is: Where and when should this
process stop? Should it be limited to the fields in which we have the
most robust data – esophageal and pancreatic surgery – or should
colorectal surgery also be included? If so, what will remain within the
field of general surgery?
In my opinion, the second and more relevant question is as
follows: Will this process of centralization have some negative
effects or drawbacks? In the manuscript, you stated that ‘‘. . .no
study identified a negative effect of high volume surgeons on the
outcome.’’ Personally, I believe that the problem is that these studies
consider only 1 side of the coin:While the quality of complex surgery
will certainly improve, is there a risk of endangering the quality of
standard general surgery? In order to reduce the rate of pancreatico-
duodenectomymortality by 1% to 2%, will we increase, for example,
the rate of bile duct lesions after cholecystectomies performed by
general surgeons, who will no longer have the chance to operate on
the liver and pancreas? What will happen to the quality of emergency
surgery in low-volume hospitals, where elective surgery for stomach,
pancreas, colorectal pathologies will disappear? How will this
influence the training and curriculum of a low-volume surgeon
operating in a low-volume hospital?
A second drawback of super specialization concerns the
introduction of new technologies. There is no doubt that numerous
advancements in the history of surgery were possible thanks to
eclectic surgeons and ‘‘contamination among specialties.’’ Laparo-
scopic surgery is the more recent example of this. Colorectal
surgeons started to perform laparoscopic resections 20 years later
than general surgeons, and as was highlighted in one of the previous
presentations at this congress, it would be impossible for a pancreatic
surgeon to become proficient in laparoscopic pancreas surgery
without having acquired a large amount of experience in a different
domain of digestive surgery, such as colorectal or bariatric surgery.
Could you please comment on this point?
Concerning the Delphi process, I think that the results are
biased by the fact that the process was limited to ESA members or
surgeons working in high-volume academic centers, which
would benefit from centralization. In order to obtain more reliable
results, I invite the authors to reproduce this survey with a wider
population of surgeons, who are representative of all aspects of
our practice.
Centralization is a crucial issue for the future of general
surgery. As I said in my Presidential lecture, the future is unwritten,
but this paper will certainly be very useful in trying to shape it.
Takeshi Sano (Tokyo, Japan):
Thank you very much for giving me the chance to comment on
this remarkable work. In Japan, centralization is very slow, as I will
tell you later. So, I learned a great deal by reading this comprehensive
study, which covers all of the issues of surgical centralization. The
study volume is enormous, and I genuinely respect this painstaking
work.
As was easily expected, or having even exceeded expectations,
the difference among the European countries was significant in almost
all aspects. As you listed in Table 2, there are many obstacles to
centralization in all levels of patients, health care providers, payers, and
politics. When we look at this list of obstacles, centralization seems to
be an impossible dream. Nevertheless, you have shown a strong
intention toward centralization, which should be praised.
First, your paper repeatedly mentions that the minimal num-
bers of cases per hospital or surgeon are difficult to define, due to a
lack of acceptable evidence, and thus, should not be the principal
requirement for centralization. In the Delphi process, you also seem
to have carefully avoided the question relating to the number of
necessary cases. Nevertheless, in the final recommendation, you
state, ‘‘The planning is based on minimal numbers of cases per
center.’’ Are you going to propose some standard numbers in the near
future, based on further studies, or are you leaving this decision to
authorities in each country?
Second, you compared the effects of hospital volume in
esophageal cancer surgery between specialized centers in the UK
and USA. The large difference is seen in hospital volume, but still,
the mortality rate was not very different – just 4% and 5% – though
you stated the difference was significant. I think that this needs
further explanation.
Third, after publishing these recommendations, what do you
expect to happen in each country? Obviously, these recommenda-
tions are from the viewpoint of academic high-volume center sur-
geons, and are not the end of the study, but rather the beginning of
ideal centralization. You should expect counterarguments or dis-
agreements from other sectors. I wish for you to successfully
continue working toward the goal.
Finally, in Japan, we have recently started a national clinical
database system (NCD), which covers more than 95% of major
surgeries performed in the country. For example, in 2011, 5300
esophagectomies were performed in 713 hospitals, and 20,011 total
gastrectomies were performed in 1623 hospitals. So, these are not at
all centralized. According to the Japanese policy, as emphasized by
the government and academic societies, people should be equally
treated wherever they live. However, this NCD also showed that,
especially in hepatobiliary pancreatic surgeries, higher volume cen-
ters have an apparently lower morbidity and mortality rate. We have
just started the centralization discussion. Cancer treatment is espe-
cially important in Japanese society, which is now the society with
the oldest population in the world, and the government has set up
some criteria to recognize cancer hospitals in each region. Currently,
we have 401 such hospitals, and the criteria include the number of
cancer surgeries, chemotherapy, MDT, ICU, palliative care, and so
on. However, this is simply a kind of service offered to the Japanese
people, and cancer patients are not required to follow this. They can
be treated anywhere they like, without any restrictions. In short, we
are starting or trying to establish some centralization, but it will
probably take a long time. Thank you.
Ronald W. Busuttil (Los Angeles, USA):
First, I wish to thank Professor Pierre Clavien for asking me to
make a few comments on this important Special Lecture, and specifi-
cally, from a US perspective. As presented in the talk, centralization of
surgical care has been discussed and attempted inmany countries, as it
Vonlanthen et al Annals of Surgery  Volume 268, Number 5, November 2018
722 | www.annalsofsurgery.com  2018 Wolters Kluwer Health, Inc. All rights reserved.
 Copyright © 2018 Wolters Kluwer Health, Inc. All rights reserved.
was first introducedmore than 4 decades ago. However, it is only in the
past 5 to 10 years that its benefit to patients, outcomes, education, and
cost reduction are now being realized.
The acceptance of centralization of surgical care is, in many
cases, dependent on the Payer System, degree of complexity of the
surgical illness, and specific type of insurance coverage, which is
particularly pertinent in the US. Perhaps, this is one of the reasons for
which centralized care has not taken on the same kind of expansive
acceptance as it has here.
Patients undergoing tertiary and quaternary procedures appear
to have been the greatest beneficiaries of centralization, showing
improved outcomes and more cost-effective results. Transplantation
is one of the unique examples of tertiary and quaternary care, which
has unequivocally shown the benefits of centralization on patient
outcomes and the reduction of resource utilization.
If one considers liver transplantation, which is acknowledged
as one of the most complex quaternary procedures, due to illness
severity, technical complexity, and the frequent association of severe
comorbidities, then there is no question that limiting the procedure to
only highly qualified centers in the US has resulted in improved
outcomes and a decreased cost of care. In the US, the centralization
of surgery of all solid organ transplantation has directed patients with
a higher risk and higher complexity to centers, which provided over
50% of all solid organ transplants. In addition, they are the facilities
that provide care for our complex patients, such as >50% of trauma
victims, burn victims, and ICU bound pediatric patients. Commen-
surate with their outstanding care, they provide unique opportunities
for research, academic advancement, and training in the future
leaders of surgical care.
Another benefit of centralizing care of transplant recipients,
which we have just realized, is the increasing use of free-standing
organ retrieval centers. One of the first in the US was in St. Louis, but
now they are expanding to other cities, such as Philadelphia, Denver,
Chicago, and Los Angeles. Performing the organ harvest at a central
facility has been shown to decrease ischemia time, offer a more
consistent protocol in organ procurement, and reduce costs by 30%
or more.
Transplant surgery has not been the only discipline to show an
encouraging trend in both patient outcomes and cost-effectiveness. A
recent study from the University of Barcelona, authored by Professor
Prades and colleagues, showed that the centralization of management
of patients with rectal cancer surgery resulted in a better quality of
care and unparalleled adherence to clinical guidelines. There are also
other examples of this phenomenon in patients undergoing complex
pancreatic, cardiac and aortic surgery, where the results after cen-
tralization in the US are superior and more cost-effective for the
patients and providers. The efficacy and improved patient care from
centralization has indeed been demonstrated, and in my opinion, will
continue to expand in the United States in the future, although at a
slower pace than it has in Europe.
I would like to know what the guidelines and requirements are
for a specific hospital and its surgical providers to become a center of
excellence. Obviously, experience and documented patient outcomes
are paramount. However, are there specific guidelines, relating to
hospital and professional cost, which have to be taken into consid-
eration? This is certainly an issue in the United States.
I would like to thank the association for the privilege of
commenting on this important paper.
Response from Pierre-Alain Clavien (Zurich,
Switzerland):
I would like to thank the 3 discussants for reading our paper as
well as commenting on this complex and controversial topic. The
Council of the ESA has selected the issue of centralization with the
intention of investigating country-specific policies and applications,
in order to critically review available data, and eventually,
propose recommendations.
First, I would like to address our President’s challenge – and
correspondingly, Professor Sano’s third comment – as to whether our
opinion is biased, as we mostly represent the academic world, where
centralization largely occurs. I believe that the ESA, which is one of
the most prestigious academic associations of specialized surgeons,
must not only be actively engaged in this discussion but also present a
strong, unified voice concerning this topic. Importantly, however, our
recommendations must be exclusively based on the patients’ per-
spective. In the discussion of the manuscript, we list strong argu-
ments calling for caution when considering other perspectives, which
logically intend to preserve interests that distance themselves from
the best available care for patients. For example, surgeons or
hospitals represent major factors that prevent effective centralization.
Typically, national societies of general surgeons are opposed to the
process of centralization, as many members may perform few
complex procedures each year, and actively lobby against centrali-
zation at their respective health authorities, claiming that the good
results they obtain render it unnecessary.
Opponents of centralization have used the lack of reliable data
at national levels, which demonstrates the correlation between center
volume and outcome, as their main argument against it. Politicians
also tremble, when it comes to the idea of reducing activities at local
hospitals, even when this would only implicate a few cases per year,
as their main concern is to be re-elected. Again, embedded in the
increasingly accepted notion of ‘‘value-based medicine,’’ which
focuses on the best interest of the patients, the concept of centrali-
zation becomes straightforward. It is common sense that patients
greatly benefit when complex diseases are handed over to experts.
The point about ‘‘hyper-specialization,’’ or when to stop the
process of specialization, as well as the possibility that this may have
a negative impact on the training of general surgeons, is indeed
crucial andmust be addressed at each country level, in order to secure
a balance between general surgeons and specialists. It is important to
keep in mind that complex procedures justifying centralization
represent less than 5% of all of the cases within general surgery.
Thus, the impact on hospital or surgeon volume is moderate at
worst. The process of centralization must be done in networks, as
outlined in the paper. If hospitals are scattered across different
regions, then there is a need to establish solid links with other
hospitals of different sizes, so that patients can be transferred and
have an adequate work-up and follow-up, when needed. The rotation
of general surgeons at specialized centers, particularly during train-
ing, is highly advisable.
Another point is that ESA recommendations for centralization
focus on the treatment of a disease, rather than a specific procedure.
For instance, centers should cover pancreatic cancer with all associ-
ated therapies, rather than only concentrating onWhipple operations.
Patients do not simply need a competent surgeon but also a compe-
tent hospital with other specialists available. A competent center
must manage complex diseases by having an interdisciplinary team
of experts available around the clock.
Professor Morino emphasizes the role of cross-fertility in
novel technologies among various fields of surgery. This is also
an important point, which may justify the clustering of several
complex diseases at the same centers (eg, cancer of the esophagus,
pancreas, and rectum at 1 tertiary center). However, I believe that
robotic surgery will soon become a common practice in many fields,
rendering cross-fertilization less imperative. Finally, exchanges cov-
ering nothing less than the world through innovative connectivity
technologies will soon replace cross-fertilization at simple centers.
So, I must admit that I do not share this concern.
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Professor Sano, you comment that centralization seems to be
an ‘‘impossible dream.’’ As discussed in the paper, if we eliminate the
obstacles and continue to focus on the patients, then this dream may
become a reality. Potential negative factors associated with centrali-
zation, such as access to information and contact details, lengthy
waiting times for highly specialized surgery, and continuity of care
with local providers, must be carefully addressed. For example, Dr
Vonlanthen addressed the issue of a patient’s willingness to travel,
which requires patient education about the benefits of being treated at
a specialized center. The Delphi exercise identified that the media
must also participate in the process of centralization by diffusing
proper information.
Your last question, Professor Sano, concerns the comparison
of mortality rates of esophagectomies in the USA and the UK. In the
UK, we had around 7500 esophagectomies in 66 centers, whereas in
the USA, 6000 cases were treated in 775 centers! There is a
significant difference between the 2 countries, with regards to overall
mortality rate (4% for UK vs 5% for USA). Now, if you restrict the
comparison to the highest volume centers in the US, the mortality
rate falls to 2.1%, which is better than the high-volume centers in the
UK. This is an argument in favor of centralization.
Regarding your question about the Delphi process, there were
indeed several statements, which require adjustment. For example,
you asked how we should select the centers for centralization. Only
taking volume into consideration is clearly insufficient. The consen-
sus tends to recommend catchment areas and minimum numbers,
although a uniformly acceptable figure for the number of cases could
not be identified. There is also a need to clearly define which
resources (eg, infrastructure, materials, and personnel) are needed
for a center to be considered as high-volume. However, the decision
about how many centers there should be and their location remains
country-specific. For example, Switzerland – a small country with 8
million inhabitants and 3 national languages – would benefit from a
distribution that respects the cultural issues at play within the
country. In the end, if we use value-based medicine parameters,
patient outcome that is grounded on a disease, and not only surgery,
must be closely monitored.
Professor Busuttil, I would like to thank you for also present-
ing the US perspective and the example of transplantation. With
regards to your last question, as I just discussed, it is clear that a
center of excellence cannot qualify as such, if patient outcomes are
poor. There is a need for international benchmark comparisons,
which we emphasized in the Delphi-based recommendations.
Regarding resources, we agree that this is the responsibility of the
health authority or government within the country. If politicians
agree to establish a center of excellence, they must be responsible for
providing the hospital or center with adequate resources. Indeed, it is
our responsibility to define what a center of excellence encompasses
by presenting guidelines or minimum requirements, such as the ESA
recommendations, in order to secure proper care.
Again, I wish to thank our President and both renowned
discussants from Japan and the USA for their input, and the associa-
tion for trusting the group from Zurich to coordinate this special
lecture among all ESA countries.
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